MDDRX
Price
$9.97
Change
+$0.05 (+0.50%)
Updated
Jul 3 closing price
Net Assets
339.94M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

MDDRX vs VIVAX

Header iconMDDRX vs VIVAX Comparison
Open Charts MDDRX vs VIVAXBanner chart's image
MassMutual Diversified Value R4
Price$9.97
Change+$0.05 (+0.50%)
VolumeN/A
Net Assets339.94M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
MDDRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MDDRX vs. VIVAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDDRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. MDDRX (340M). VIVAX pays higher dividends than MDDRX: VIVAX (2.06) vs MDDRX (1.31). MDDRX was incepted earlier than VIVAX: MDDRX (11 years) vs VIVAX (33 years). MDDRX (1.09) is less costly to investors than VIVAX (0.17). MDDRX is a more actively managed with annual turnover of: 46.00 vs. VIVAX (9.00). MDDRX has a lower initial minimum investment than VIVAX: MDDRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. MDDRX (-16.51). VIVAX return over 5 years is better than : 80.14 vs. MDDRX (14.99).
MDDRXVIVAXMDDRX / VIVAX
Total Expense Ratio1.090.17641%
Annual Report Gross Expense Ratio1.090.17641%
Fund Existence11 years33 years-
Gain YTD7.5516.209122%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets340M189B0%
Annual Yield % from dividends1.312.0664%
Returns for 1 year-16.5112.04-137%
Returns for 3 years-8.9035.16-25%
Returns for 5 years14.9980.1419%
Returns for 10 years-20.20115.74-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIO30.850.21
+0.69%
ALPS Medical Breakthroughs ETF
IVOG115.440.56
+0.49%
Vanguard S&P Mid-Cap 400 Growth ETF
OIA5.790.01
+0.17%
INVESCO Municipal Income OPPORTUNITIES TRUST
BBAGF42.50N/A
N/A
BB Biotech AG
LRND36.17N/A
N/A
NYLI U.S. Large Cap R&D Leaders ETF